Pure Global AI
NCT06378879Not yet recruiting

Intermittent Boluses Versus Infusion of Propofol During Gastroscopy

Intermittent Boluses Versus Continuous Infusion of Propofol During Standard Upper Endoscopy
Al-Balqa Applied UniversityClinicalTrials.govdrug
Study focus
Disease/Condition
Anesthesia
Drug/Device/Intervention
Propofol 100 MG in 10 ML Injection
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Al-Balqa Applied University
Timeline & enrollment
Phase
N/A
Start date
May 06, 2024
End date
Jul 30, 2025
Enrollment
100 participants
Primary outcome

Sedation induction time (minutes),Total dose of propofol (mg),Recovery time (minutes)

Summary

It is unclear whether continuous infusion or intermittent bolus injection of propofol is
 better for achieving adequate sedation during a standard upper endoscopy. The study aimed to
 compare the efficacy and safety of continuous infusion and intermittent bolus injection of
 Propofol (Diprivan) during a standard upper endoscopy. In this prospective study, patients
 will be randomly assigned to undergo a standard upper endoscopy with either continuous
 infusion (CI group) or intermittent bolus injection (BI group) of Propofol (Diprivan)
 administered by an anesthesiologist. The primary outcome will be to assess the quality of
 sedation by the endoscopist (VAS). In addition to other sedation-related parameters that will
 include sedation induction time (minutes), total dose of propofol (mg), recovery time
 (minutes) using Aldrete score, any involuntary patient movement, and adverse events.

ICD-10 classifications
Anaesthetic, unspecifiedOther and unspecified general anaestheticsLocal anaestheticsOther complications of anaesthesiaComplication of anaesthesia during labour and delivery, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06378879
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06378879 through Pure Global AI's free database. This phase not specified trial is sponsored by Al-Balqa Applied University and is currently Not yet recruiting. The study focuses on Anesthesia. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.